Abstract
Objectives
This prospective study aimed to examine the association of psychosocial working conditions with adverse reactions after receiving COVID‐19 vaccination in a sample of employees in Japan.
Methods
The data were retrieved from an online panel of full‐time employees (E‐COCO‐J). The analysis included participants who were employed and were not vaccinated at baseline (June 2021) but received vaccination at a 4‐month follow‐up (October 2021). An 11‐item scale measured the adverse reactions. Four types of psychosocial working conditions (i.e., job demands, job control, and supervisor and coworker support) were measured using the Brief Job Stress Questionnaire. Multiple linear regression analyses were conducted to examine the relationship between the psychosocial working conditions and adverse reactions of COVID‐19 vaccines, adjusting for socioeconomic variables, chronic disease, the number of vaccination, type of vaccine, anxiety for adverse reactions, fear and worry about COVID‐19, and psychological distress at baseline.
Results
Overall, 747 employees were included in the analysis. The average number of adverse reactions was 3.8 (standard deviation = 2.2): Arm pain (81.1%), fatigues (64.1%), muscle pains (63.3%), and fever (37.5°C+) (53.5%) were reported more frequently. Coworker support score was significantly and negatively associated with the numbers of adverse reactions (standardized
Conclusions
Employees with low coworker support may be more likely to have adverse reactions after vaccinations. The findings of this study could support that increasing workplace support may reduce adverse reactions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Kuroda, Reiko 2
; Tsuno, Kanami 3
; Imamura, Kotaro 1
; Kawakami, Norito 1
1 Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2 Division for Environment, Health, and Safety, The University of Tokyo, Tokyo, Japan
3 School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan





